Shows
BioSpaceSarepta Gets Reprieve, RFK Jr.’s New Changes, Roche’s Alzheimer’s Comeback and Q2 EarningsThe Sarepta saga continued into another week as the FDA recommended that the voluntary hold on the company’s Duchenne muscular dystrophy gene therapy be lifted for ambulatory patients, after determining that the death of an 8-year-old Brazilian Duchenne patient who had received Elevidys’ was not caused by the drug. Sarepta’s stock has swung wildly and its transparency questioned after it elected not to reveal the death of a third patient—a participant in a trial of a gene therapy for limb girdle muscular dystrophy—during a business update last week. Speaking of entities—or individuals—who have trouble...
2025-07-3019 min
Pharma and BioTech DailyPharma and Biotech Daily: New Novo Nordisk CEO, FDA Reversal on Sarepta, and MoreGood morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Novo Nordisk has announced Maziar Mike Doustdar as its new CEO, along with a 5% reduction in its 2025 sales guidance. This decision comes as a response to the slowed growth of its semaglutide franchise in the U.S. Senate Democrats are currently looking into HHS Secretary RFK Jr.'s controversial move to dismiss all 17 members of the CDC's vaccine advisory committee. Astrazeneca CEO Pascal Soriot emphasized the importance of global collaboration in pharmaceutical research and development. Merck has allocated $3...
2025-07-3000 min
Bloomberg TalksAstraZeneca CEO Talks Drug Sales in USAstraZeneca may sell some of its medicines directly to patients in the US, according to Chief Executive Officer Pascal Soriot. AstraZeneca is looking to the US for growth, with Soriot saying the company will be self-sufficient in the US in a couple of months. He speaks with Bloomberg's Carol Massar, Tim Stenovec, and Madison MullerSee omnystudio.com/listener for privacy information.
2025-07-2914 min
OWITH.ai - Only What's Important to Hear around AI and TechAI Advancements, Tech News, and Market Insights on OWITH.aiGood morning from OWITH.ai: the podcast that gives you only what's important to hear in AI and tech world.Eric Xing is leading an ambitious project at MBZUAI in Abu Dhabi to establish American-style research norms in AI, promoting open research and democratizing access to cutting-edge tools. The UAE aims to build soft power in AI through MBZUAI, positioning it as a competitor to elite institutions like MIT and Carnegie Mellon. Xing's emphasis on transparency in advanced AI reasoning models reflects the region's push for responsible AI development. The White House plans to boost global export of U.S...
2025-07-2302 min
Squawk Box Europe ExpressSenate narrowly passes President Trump's megabillThe Senate narrowly passes Trump's sweeping tax and spending bill, with attention now turning back to the House as it races to pass the package. Fed Chair Jerome Powell appears to push back at pressure from President Trump, telling the Sintra forum the Fed would have cut rates further by this stage if it had not been for tariffs. Shares in AstraZeneca pop in Tuesday's session after the Times reports CEO Pascal Soriot is looking at moving the pharma giant's listing from London to the U.S. And - Santander swoops in for Sabadell's U.K. unit TSB in...
2025-07-0225 min
Bloomberg Daybreak: Europe EditionStarmer’s Costly U-Turn, Astra's UK Listing Risk, Trump Bill Rebellion BrewsYour morning briefing, the business news you need in just 15 minutes. On today's podcast: (1) Keir Starmer dramatically abandoned his flagship welfare reforms to avoid a historic defeat, leaving the UK prime minister’s authority badly damaged and his government facing a widening fiscal hole to fill. (2) The Trump administration is halting the transfer of artillery rounds and air defenses to Ukraine, depriving the country of much-needed weapons as it endures stepped-up missile and drone attacks from Russia. (3) President Donald Trump said Israel has agreed to the conditions needed for a 60-day cea...
2025-07-0221 min
China Business NOWChina pledges expanded market access for foreign investorsHi everyone. I’m Stephanie LI.Coming up on today’s programPremier Li Qiang pledges to expand market access for foreign investors at high-level economic forum in Beijing; "Ne Zha" franchise slays Chinese film record with 20 billion yuan earnings.Here’s what you need to know about China in the past 24 hours Reiterating China's commitment to openness and global collaboration, Chinese Premier Li Qiang said on Sunday that China will further expand market access in various sectors for foreign investors.Deliveri...
2025-03-2409 min
Imagen EmpresarialImagen Empresarial 03 MAR 25Podcast del programa Imagen Empresarial transmitido originalmente el 3 de marzo del 2025. Conduce Rodrigo Pacheco.
Los entrevistados de hoy:
Brian Rodríguez Ontiveros, analista Bursátil de Monex
Tema:
¿Qué empresas fueron las ganadoras y perdedoras de la temporada de reportes corporativos en México?
Agenda económica más relevante de la semana
Pascal Soriot, CEO de AstraZeneca
Tema: Actualidad de Astra y negocio en México
2025-03-0347 min
Rodcast, con Rodrigo PachecoT2 E7 Pascal Soriot - Ceo global de Astra ZenecaEn este episodio, tiene una conversación exclusiva con Pascal Soriot, CEO global de AstraZeneca, quien comparte su visión sobre el futuro de la industria farmacéutica, los avances en innovación y la sostenibilidad en la salud. Soriot habla sobre los desafíos y oportunidades que enfrenta la compañía en el panorama global, así como su enfoque en la investigación y el desarrollo de tratamientos que transforman la vida de millones de personas alrededor del mundo. Un episodio lleno de insights sobre liderazgo, ciencia y el impacto de la biomedicina en la sociedad.
2025-03-0347 min
Canny Conversations Podcast by Safaraz AliKim Hardman, AstraZeneca’s Director of Apprenticeships - Part 1Kim Hardman, AstraZeneca's Director of Apprenticeships, opens up about her extraordinary 23-year journey with the company, offering a unique insider perspective on the evolution of apprenticeships in the world of science and technology. Under the leadership of CEO Pascal Soriot, Kim has not only witnessed, but actively contributed to the company's transformation, particularly through her work with apprentices in the UK and pioneering science apprenticeship programs in the US. She passionately discusses how early career talent brings invaluable fresh perspectives, transforming the traditional view of apprenticeships into a dynamic path for innovation and growth.As the conversation...
2024-12-1333 minBloomberg TalksAstrazeneca CEO Pascal Claude Roland Soriot Talks China Compliance In Wake of Staff DetentionsAstraZeneca Plc has strong compliance policies in China and is working closely with authorities following the detention of several employees in the country, Chief Executive Officer Pascal Soriot joins Bloomberg's Francine Lacqua.See omnystudio.com/listener for privacy information.
2024-09-1012 min
Bloomberg IntelligenceTesla, Boeing, UPS Earnings, Morning Consult PollWatch Alix and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.On this week’s podcast, hosts Paul Sweeney and Guest-Host Molly Smith speak with Steve Man, Bloomberg Intelligence Global Autos and Industrials Research Analyst, on Tesla earnings. Anurag Rana, Bloomberg Intelligence Technology Analyst, and Sunil Rajopal, Bloomberg Intelligence Senior Software Analyst, talk about how Salesforce’s takeover talks with Informatica are said to be cooling off. Lee Klaskow, Bloomberg Intelligence Senior Transport, Logistics and Shipping Analyst, discusses UPS earnings. Gregory Korte, Bloomberg News White House and Political Correspondent, talks about the latest Bloomberg News morn...
2024-04-2639 minBloomberg IntelligenceMeta Misfire, Market SelloffWatch Alix and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF. David Kirkpatrick, Founder of Techonomy, recaps Meta earnings, and also previews Alphabet and Microsoft earnings. Ira Jersey, Bloomberg Intelligence Chief US Interest Rate Strategist joins to discuss economic data in U.S. Barry Ritholtz, Founder of Ritholtz Wealth Management and Host of “Masters in Business” talks about today’s market selloff. James Abate, Managing Director & Chief Investment Officer, at Centre Asset Management, discusses the latest on the markets. Pascal Soriot, CEO of AstraZeneca, discusses AstraZeneca earnings.Hosts: Paul Sweeney and Molly SmithSee...
2024-04-2547 minChina Business NOWGlobal CEOs flock to China, embracing new opportunities in high-quality growthChina is taking the absolute centre stage this week.Executives of multinationals, representatives from international organizations and foreign institutions, as well as world-renowned scholars have flocked to the country, attending the ongoing Boao Forum for Asia Annual Conference 2024 and the China Development Forum (CDF) 2024 that concluded on Monday, offering insights into China's development and its global impact. This year's CDF drew more than 110 international guests, including the heads of the World Bank and the IMF, as well as executives of many Fortune 500 companies. Most remarkably, of the more than 80 business executives listed by the CDF, o...
2024-03-2911 min
Ekonomiekot ExtraBörsraketerna som tjänar på fetmarevolutionen — risk för ”explosion” av kostnaderDiabetesmedicinen Ozempic har blivit en säljsuccé, och läkemedelsbolagen Novo Nordisk och Eli Lilly täljer guld på den marknad som öppnat sig för de nya fetmamedicinerna. Frågan är vem som ska betala samhället eller patienterna? Lyssna på alla avsnitt i Sveriges Radio Play. Programledare:Hanna MalmodinMedverkande och röster i programmet:Karolina Antonov, chefsstrateg, branschorganisationen LifSara Heyman, global hälsokorrespondent, Sveriges RadioMikael Svensson, läkemedelshandläggare, Sveriges Kommuner och regionerYlva Trolle Lagerros, överläkare, Karolinska sjukhusetLars Fruergaard Jörgensen, vd, No...
2024-02-0924 min
The Oxford ColloquyThe Pandemic People: Sir Pascal SoriotSir Andrew Pollard talks to Sir Pascal Soriot, the CEO of AstraZeneca about their pandemic partnership to develop the AstraZeneca/Oxford vaccine. Over three billion vaccines have been delivered, saving six and a half million lives. It’s a reunion in this episode of the Oxford Colloquy, as Sir Andrew Pollard talks to Sir Pascal Soriot, the CEO of AstraZeneca (AZ), about their pandemic partnership to develop the AstraZeneca/Oxford vaccine. Although, as you’ll discover, they have more than vaccines in common.
From his early childhood in a relatively poor suburb of Paris, that included a love of horses, Sir...
2023-11-2740 min
The So What from BCGDo Pharma CEOs Have the Prescription for a Net Zero World?Ahead of COP28, the UN’s climate conference, we explore the unique ways public-private partnerships help achieve sustainability goals. Lars Fruergaard Jørgensen, CEO of Novo Nordisk; Pascal Soriot, CEO of AstraZeneca; and Christine O’Brien, lead for BCG’s climate and sustainability practice in health care, discuss the projects and success of the Sustainable Markets Initiative Health Systems Task Force. The Task Force brings together global health leaders to enhance individual, societal, and planetary health. Together, they have launched sector-first commitments, actions, and recommendations to accelerate the delivery of net zero, patient-centric health systems. Learn Mo...
2023-11-2224 min
Collecting COVID: Oral HistoriesProfessor Sandy Douglas (part two)Georgina Ferry interviews Sandy Douglas, Associate Professor (Jenner Institute), 17 March 2022. Topics discussed include (00:00:20) initial questions relating to the large-scale manufacturing of the vaccine, including early ideas relating to a University spin-out company, the decision to partner with AstraZeneca to manufacture and distribute the vaccine; (00:04:25) steps taken to implement the partnership with AstraZeneca, including the decision by John Bell in relation to establishing a partnership, equitable access, early communication with Merck and work with the Serum Institute of India and WuXi Biologics, priorities of the University; (00:09:55) major contribution of the Oxford-AstraZeneca vaccine, including the speed of delivery, willingness to partner so...
2022-11-021h 11Collecting COVID: Oral HistoriesProfessor John Bell (part one)Georgina Ferry interviews Sir John Bell, Regius Professor of Medicine, 22 February 2022. Topics discussed include (00:00:18) JB's early interest and training in medicine, work with Sir David Weatherall, studies as Rhodes Scholar at Oxford and Stanford and later work at Oxford including as Nuffield Chair of Medicine and Regius Professor of Medicine; (00:01:10) interest in the mechanisms of different diseases and molecular medicine; (00:02:12) the evolution and expansion of medicine at Oxford; (00:07:05) involvement in public and national bodies, including the Academy of Medical Sciences, the Office for Strategic Coordination of Health Research, Roche and work with David Cooksey; (00:12:44) nomination as Life Sciences Champion for...
2022-11-0249 min
The Brave New World OrderCurrent Events Episode #2 - Watch the Water Debunked? Hunter Biden Food Shortages & Cursed Tablet found in Mt. Ebal!Welcome to The Brave New World Order. Join me, Brandon St. One, as I take a look at the recent substack article by Dr. Pierre Kory debunking Watch the Water! I also look at the recent Hunter Biden Laptop from hell release, multiple food processing facilities destroyed so far in 2022 and Project Veritas catching Astra Zeneca CEO Pascal Soriot on film with some damning statements. Just for fun I talk about an ancient proto-hebrew tablet found in Mt. Ebal that is the earliest writing found with the words Yahweh. What's even more interesting is the tablet is cursed! Check...
2022-04-2128 min
Worldwide ExchangeAstraZeneca CEO, Disney’s earnings beat, Congressional stock tradesThe CEO of AstraZeneca, Pascal Soriot, joins Meg Tirrell to discuss the companies earnings and its Covid treatments. Plus, Disney beat on earnings and subscriber numbers and the stock is up big. John Hodulik of UBS joins to discuss his bull case. And Brian takes a look at the biggest Congressional stock trades happening lately, and who’s making them.
2022-02-1045 min
The Sky News Business PodcastVaccine profits, lottery highs and four-day weeks.On today's episode, AstraZeneca's chief executive Pascal Soriot tells Ian King poorer countries will be spared its decision to start making profit on its coronavirus vaccines. Ian also finds out what's driving a rise in lottery ticket sales, and he hears from the company making a four-day week work.
2021-11-2338 min
The Sky News Business PodcastVaccine profits, lottery highs and four-day weeks.On today's episode, AstraZeneca's chief executive Pascal Soriot tells Ian King poorer countries will be spared its decision to start making profit on its coronavirus vaccines. Ian also finds out what's driving a rise in lottery ticket sales, and he hears from the company making a four-day week work.
2021-11-2338 min
Money Tips Daily by Charles Kelly, former IFA and author ofCan Employees Get Rich Working For Others? The Answer Might Surprise you!Can You Get Rich As An Employee?
My answer might surprise you…
The highest paid FTSE 100 company executive is the CEO of pharmaceutical giant Astra Zeneca, Pascal Soriot, who earned £15.45 million in 2020 for his part in delivering the covid vaccine to tens of millions of people.
The median FTSE CEO was paid £2.69 million – 86 times the median full-time worker - in 2020, according to the High Pay Centre think tank.
The boss of the credit search agency Experian, Brian Cassin, earned £10.3 million, but CEOs of PLC companies are not the highest paid people in the...
2021-08-1917 min
The CEO DialoguePascal SoriotPascal Soriot has been described as the hottest CEO in Pharma. After almost a decade at the helm of AstraZeneca, the company has seen a remarkable turnaround - battling falling sales to become one of the most valuable companies on the FTSE 100.For many, the drugmaker is synonymous with its coronavirus vaccine, but the source of Astrazeneca’s success traces back long before the pandemic. This week, Pascal Soriot tells IMD President Jean-François Manzoni about the future of the pharmaceuticals industry and the need to build a greener and more sustainable world.
2021-08-0524 min
ProfilePascal SoriotAstraZeneca's CEO faces scrutiny as his company's vaccine, and its roll out, comes under fire. Mark Coles explores the life and career one of big pharma's biggest names.
The oldest of four boys, Pascal Soriot grew up in a working class area of Paris. He took the helm at AZ in 2012 after years in top jobs across the world. One of his first challenges was to fight off a takeover from Pfizer. The AZ vaccine, currently not-for-profit, was hailed as a life saver for millions. But with accusations of confusing drug trial data, dishonest dealings with the EU and...
2021-03-2713 min
The Readout LoudEpisode 153: AstraZeneca and the very good, then quite bad, then deeply confusing weekWe're devoting this week's episode to the week of whiplash news about AstraZeneca's Covid-19 vaccine, subject of a baffling international incident with consequences still unfolding. First, we explain the series of late-night announcements that made global headlines. Then, our STAT colleague Helen Branswell joins us to discuss the implications for AstraZeneca, vaccine confidence, and the global effort to get doses in arms. Finally, STAT's Matthew Herper calls in to talk about Pascal Soriot, the hard-charging AstraZeneca CEO whose previously feted boldness might have backfired when it came to Covid-19.
2021-03-2527 min
On parle d'euxPascal Soriot : l’incroyable parcours du (discret) patron d’AstraZenecaAlors que les polémiques s'accumulent autour du vaccin AstraZeneca contre le Covid-19, "On parle d'eux" dresse le portrait de Pascal Soriot, le PDG du laboratoire anglo-suédois. Voir Acast.com/privacy pour les informations sur la vie privée et l'opt-out.
2021-03-2409 min
Talking Shop PodcastThe Boom in Companies Spying on Employees, and AstraZeneca's Loss of TrustWorkers often suspect their bosses may be spying on them, either via security cameras or software that can track their internet use. But as Ewan explains this week, it's gotten much, much worse than that. New, more invasive technology is driving a boom in companies surveilling their staff with tools like real-time monitoring of staff computer screens, keystroke logging, and more. Ewan details what's going on and how workers can try and protect themselves.
COVID-19 remains a dark cloud over most of the world, but there's genuine excitement about the ramping up of vaccinations -- with the possible exception of...
2021-03-2247 min
Donau Tech Radio - DTRM1, AmpliFi, Thunderbolt Docks, Impfung und Clubhouse
Diese Episode startet ungewohnt technisch mit Toms Ausführungen zur Migration seiner Anwendung auf Spring 5 sowie Spring Boot. Danach geht es weiter mit Andrés neuem WiFi Setup das mit Hilfe von AmpliFi Geräten emporgehoben wurde. Neben den AmpliFi Geräten geht es dieses Mal von der Gadget-Seite her auch noch um Thunderbolt 3 Docks, André berichtet vom Dock seiner Wahl. Zu guter Letzt geht es noch um ein Thema das diese Woche in aller Munde war: Clubhouse.
Wir wünschen gute Unterhaltung!
Shownotes
StudioLink Standalone für M1TestcontainersJunit 5SQL CTEsAmpliFiAmpliFi Home Wi-Fi System...
2021-02-011h 29
TRSIStand patiently, suffer in silence, and waithttps://ec.europa.eu/info/sites/info/files/curevac_-_redacted_advance_purchase_agreement_0.pdfhttps://www.repubblica.it/cronaca/2021/01/26/news/interview_pascal_soriot_ceo_astrazeneca_coronavirus_covid_vaccines-284349628/
2021-01-2756 min
Inside Covid-19Inside Covid-19: vaccine roll-out in SA, beyond - experts, pharmacy bossesWith billions of dollars a day disappearing as much of the northern hemisphere is shutdown to contain the spread of Covid-19, it is critical for vaccines to be rolled out as soon as possible. In this episode of Inside Covid-19, we focus on vaccine roll out in Africa and elsewhere. Coming up: We hear from Professor Shabir Madhi, vaccines expert at the University of the Witwatersrand, and Chief Executive Officer of AstraZeneca Pascal Soriot who says supply partners are getting ready to produce hundreds of millions of doses of their vaccine. Also in the programme, Nobel Laureate, Michael Kremer, shares...
2020-11-3029 min
Inside Covid-19Inside Covid-19: vaccine roll-out in SA, beyond - experts, pharmacy bossesWith billions of dollars a day disappearing as much of the northern hemisphere is shutdown to contain the spread of Covid-19, it is critical for vaccines to be rolled out as soon as possible. In this episode of Inside Covid-19, we focus on vaccine roll out in Africa and elsewhere. Coming up: We hear from Professor Shabir Madhi, vaccines expert at the University of the Witwatersrand, and Chief Executive Officer of AstraZeneca Pascal Soriot who says supply partners are getting ready to produce hundreds of millions of doses of their vaccine. Also in the programme, Nobel Laureate, Michael Kremer, shares...
2020-11-3029 min
DCAT Value Chain Insights’ Production to PrescriptionTop 10 Watch List: Pharma CEOs on the RiseIn this podcast we feature a list of the Top 10 pharma CEOs to watch in 2020. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers)Pharma CEOs to watch in 20201. Three-way tie: Pfizer, J&J, and AstraZeneca.Pfizer Chairman and CEO Albert BourlaJ&J Chairman and CEO Alex GorskyAstraZeneca CEO Pascal Soriot4. Moderna CEO Stéphane Bancel5. Gilead Sciences Chairman and CEO Daniel O’Day6. Regeneron Pharmaceuticals Co-Founder, President and CEO Leonard S. Schleifer7 (tie). CureVac CEO Franz-Werner Haas and Novavax CEO and President Stanley C. Erck9. Seagen (formerly Sea...
2020-10-2318 min
PharmaPills - Pillole dal farmaceuticoPharmapills puntata n.118. AIFA autorizza 4 nuovi studi clinici sul COVID-19PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano Lagravinese.In questa puntata parliamo di:Bayer, AstraZeneca, Pfizer e BioNTech, Telethon e Associazioni pazienti, Plasma, Nuovi studi anti Covid-19.Aziende: AstraZeneca, Bayer, Pfizer, BioNTech.Persone: Chris Gibson (Bayer), Pascal Soriot (AstraZeneca), Ugur Sahin (BioNTech), Pierre Tiberghien (Eba).Nuove terapie: Terapie a base di plasma da convalescente, Ruxolitinib.Patologie: COVID-19.Lavoro: Clinical Project Manager, CRA.Il mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su:
2020-09-1609 min
Logo Cedo PodcastEpisódio 23 - 11/09/2020Brasil tem maior queda em média de casos de Covid registrados desde o início da pandemia
O Brasil chegou nesta quinta-feira (10) a 129.575 mortes e 4.239.763 casos confirmados de coronavírus. Com 922 mortes registradas em 24 horas.
Voluntária que teve reação após vacina da AstraZeneca contra a Covid-19 não tomou placebo
A voluntária que apresentou reações durante os testes com a vacina contra a Covid-19 é uma mulher britânica que não faz parte do grupo placebo e recebeu, de fato, uma dose do imunizante, disse na quarta-feira (9) o presidente d...
2020-09-1105 minLogo Cedo PodcastEpisódio 22 - 10/09/2020Brasil volta a ter mais de mil mortes em 24 horas, mas segue em tendência de queda na média móvel
O Brasil chegou ontem a 128.653 mortes e 4.199.332 casos confirmados de coronavirus. 1.136 mortes registradas em 24 horas.
Presidente da AstraZeneca afirma que voluntária de vacina teve sintomas neurológicos e pode ter alta nesta quarta
O presidente da farmacêutica AstraZeneca, Pascal Soriot, disse ontem, em uma reunião com investidores, que os testes com a vacina contra a Covid-19 foram pausados depois que uma voluntária apresentou sintomas que podem estar vinculad...
2020-09-1004 min
RethinkPascal Soriot: Rethinking Medical Co-operationCEO of AstraZeneca, Soriot praises the example shown by scientists working together.
2020-06-3008 min
O YE DRYBONES (FEB 2019 - JAN 2025)The Helios Biblios Hour : Far Left + Far Right= THE PURGE COVID 19By the 19th century, Great Britain and Germany were recognized as the primary geographic areas of Illuminati control. It then should be of little surprise to know the first work in Behavioral Science research was established in England in 1882, while much of the early medical and psychiatric techniques involved in mind control were pioneered at the Kaiser Wilhelm Institute in Germany. The Tavistock Institute of Human Relations was set up in London in 1921 to study the “breaking point” of humans. Kurt Lewin, a German psychologist, became the director of the Tavistock Institute in 1932, about the same time Nazi Germany was incre...
2020-05-172h 57O YE DRYBONES (ARCHIVE)The Helios Biblios Hour : Far Left + Far Right= THE PURGE COVID 19By the 19th century, Great Britain and Germany were recognized as the primary geographic areas of Illuminati control. It then should be of little surprise to know the first work in Behavioral Science research was established in England in 1882, while much of the early medical and psychiatric techniques involved in mind control were pioneered at the Kaiser Wilhelm Institute in Germany. The Tavistock Institute of Human Relations was set up in London in 1921 to study the “breaking point” of humans. Kurt Lewin, a German psychologist, became the director of the Tavistock Institute in 1932, about the same time Nazi Germany was incre...
2020-05-172h 57
Global Venturing Review11 November 2019 – Marianne Wu Moves On From GE VenturesThe Big Ones
Marianne Wu, president of GE Ventures, has left the corporate venturing unit as the US-listed industrial conglomerate has agreed to sell 16 healthcare portfolio companies to an affiliate of Leerink Revelation Partners.
Over the past few years, China has – partially out of necessity – been responsible for a lot of healthcare innovation and that hasn’t gone unnoticed by international players. AstraZeneca is the latest corporate to want a slice of the action and the pharmaceutical firm is going all in with the launch of a $1bn fund it unveiled together with investment bank CICC. No...
2019-11-1116 min
FT News in FocusLeaders under pressure: Pascal Soriot 1/4Pascal Soriot, chief executive of the Anglo-Swedish drugs company AstraZeneca, tells Andrew Hill about his 2014 battle to head off a hostile takeover bid from Pfizer of the US. Hosted on Acast. See acast.com/privacy for more information.
2016-12-2713 min
12 Noon BBC Business UpdateNigeria Corruption Plus Illegal IvoryHello I'm Russell Padmore with this Business Update from the BBC where the main headlines are:
Nigeria's finance minister admits corruption is still a huge problem.
African leaders meet in Kenya to discuss ways to stop ivory poaching and save elephants from extinction.
And shareholders continue to vote against big pay rises for bosses of global companies.
Nigeria continues to resist pressure to devalue its naira currency, despite the fears of foreign investors that the country's economic crisis will worsen. The big drop in oil prices has left the Nigerian Government with a huge hole in its budget. President Muhammadu...
2016-04-2909 min